Article Versions Notes

Chang G-R, Hou P-H, Yang W-C, Wang C-M, Fan P-S, Liao H-J, Chen T-P. Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice. Pharmaceuticals. 2021; 14(3):267. https://doi.org/10.3390/ph14030267

Chang, Geng-Ruei, Po-Hsun Hou, Wei-Cheng Yang, Chao-Min Wang, Pei-Shan Fan, Huei-Jyuan Liao, and To-Pang Chen. 2021. "Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice" Pharmaceuticals 14, no. 3: 267. https://doi.org/10.3390/ph14030267

Chang, G.-R., Hou, P.-H., Yang, W.-C., Wang, C.-M., Fan, P.-S., Liao, H.-J., & Chen, T.-P. (2021). Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice. Pharmaceuticals, 14(3), 267. https://doi.org/10.3390/ph14030267